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Abstract
Background: The dengue virus two-component protease NS2B/NS3 mediates processing of the viral polyprotein
precursor and is therefore an important determinant of virus replication. The enzyme is now intensively studied
with a view to the structure-based development of antiviral inhibitors. Although 3-dimensional structures have now
been elucidated for a number of flaviviral proteases, enzyme-substrate interactions are characterized only to a
limited extend. The high selectivity of the dengue virus protease for the polyprotein precursor offers the distinct
advantage of designing inhibitors with exquisite specificity for the viral enzyme. To identify important determinants
of substrate binding and catalysis in the active site of the dengue virus NS3 protease, nine residues, L115, D129,
G133, T134, Y150, G151, N152, S163 and I165, located within the S1 and S2 pockets of the enzyme were targeted
by alanine substitution mutagenesis and effects on enzyme activity were fluorometrically assayed.
Methods: Alanine substitutions were introduced by site-directed mutagenesis at residues L115, D129, G133, T134,
Y150, G151, N152, S163 and I165 and recombinant proteins were purified from overexpressing E. coli. Effects of
these substitutions on enzymatic activity of the NS3 protease were assayed by fluorescence release from the
synthetic model substrate GRR-amc and kinetic parameters Km, kcat and kcat/Km were determined.
Results: Kinetic data for mutant derivatives in the active site of the dengue virus NS3 protease were essentially in
agreement with a functional role of the selected residues for substrate binding and/or catalysis. Only the L115A
mutant displayed activity comparable to the wild-type enzyme, whereas mutation of residues Y150 and G151 to
alanine completely abrogated enzyme activity. A G133A mutant had an approximately 10-fold reduced catalytic
efficiency thus suggesting a critical role for this residue seemingly as part of the oxyanion binding hole.
Conclusions: Kinetic data obtained for mutants in the NS3 protease have confirmed predictions for the
conformation of the active site S1 and S2 pockets based on earlier observations. The data presented herein will be
useful to further explore structure-activity relationships of the flaviviral proteases important for the structure-guided
design of novel antiviral therapeutics.
Background
Dengue virus, a member of the Flaviviridae family, is a
small, spherical, enveloped, positive single strand RNA
virus that is transmitted to humans by mosquitoes of
the species Stegomyia aegypti (formerly Aedes). All 4
serotypes of the virus (DEN-1, 2, 3 and 4) can cause a
spectrum of clinical symptoms including mild dengue
fever (DF) and more severe forms of dengue
hemorrhagic fever (DHF) and dengue shock syndrome
(DSS) [1,2]. An increase of geographical spread, inci-
dence and severity of diseases over the past decade has
now stimulated intensive efforts to develop effective
antiviral therapeutics which are eventually useful for the
prevention and cure of dengue virus infections. The
development of small molecule drugs directed at inhibi-
tion of replication and maturation of the virus is now
considered as promising route for the treatment of
acute dengue diseases [for review see [3-5]and references
herein].
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vivirin enzyme family (EC 3.4.21.91), is located in the
N-terminal 184 residues of the multifunctional 69 kDa
NS3 protein and contains a functional catalytic triad
consisting of H51, D75 and S135 (in DEN-2) [6]. In
addition to the serine protease, the NS3 protein contains
enzymatic activities of a nucleoside triphosphatase, a 5′ -
RNA triphosphatase (RTPase) and a RNA - stimulated
RNA helicase [7,8]. The NS3 protease catalyses the
post-translational cleavage of the viral polyprotein pre-
cursor in the non-structural region at the NS2A/NS2B,
NS2B/NS3, NS3/NS4A and NS4B/NS5 sites and at addi-
tional sites within the viral capsid protein, NS2A, NS4A
and within a C-terminal region of NS3 itself [9-13]. The
overall conformation of the dengue virus NS3 protease
displays the b-barrel conformation typical for serine
proteases, although the viral enzyme appears to possess
higher compactness with short or absent loop structures
and a relatively shallow substrate binding site [14].
The presence of a small hydrophilic core segment of
approximately 40 residues, commonly designated NS2B
(H), within the small 14 kDa NS2B cofactor is required
for optimal activity of the NS3 protease [15-17]. Proteo-
lytic autoprocessing at the NS2B/NS3 site generates a
non-covalent adduct between NS2B(H) and NS3 which
is catalytically active with substrates supplied in trans
cleavage reactions [18].
Detailed substrate specificity studies have established
that the cleavage junctions in the viral polyprotein con-
sist of pairs of dibasic amino acids such as RR, RK and
KR at the P1 and P2 positions. Small, non-branched
amino acids such as S are preferred at the P1′ position
of the dengue virus cleavage site, whereas the preferred
P1′ residue of the WNV NS3 protease is G [19-21].
Theoretical molecular interactions between the active
site of the NS3 protease and the peptide substrate were
largely consistent with data obtained from substrate pro-
filing studies [22]. Crystallographic studies of flaviviral
proteases including the West Nile Virus (WNV) and
dengue virus in complex with a partial NS2B cofactor
and substrate-mimetic inhibitors such as aprotonin have
provided evidence for major structural reorganizations
of the active site pockets caused by insertion of a b-bar-
rel of the NS2B cofactor and an “induced fit” mechan-
ism of catalysis in the presence of authentic protein
substrates [23]. Based on a homology-modelled structure
of the WNV NS3 protease, residues within the S1 and
S2 pockets critical for enzyme-substrate interaction were
identified by analysis of catalytic activity of mutant pro-
teases with a synthetic peptide substrate [24]. Structural
data obtained recently for a WNV NS2B-NS3pro pro-
tease in complex with a substrate-based tripeptide inhi-
bitor have revealed a catalytically competent oxyanion
binding site formed by two residues, G133 and S135,
and substitution of the active-site nucleophile serine by
alanine does not result in a disruption of the oxyanion
conformation [25]. It is noteworthy that also in the pre-
sence of ligands without a P1′ residue the active confor-
mation of the oxyanion hole is adopted by the viral
protease.
A high conservation of sequences within the faviviral
proteases suggests that specificity characteristics found
for the WNV protease could also be of relevance for the
closely related dengue virus NS3 protease. Despite their
overall similarities, the NS3 proteases from dengue virus
and WNV exhibit different substrate specificities, sug-
gesting a distinct organization of their respective active
site conformations [21].
In analogy to procedures previously described for the
enzyme from WNV, we have identified key residues for
substrate binding and catalysis of the dengue virus NS3
protease by alanine substitution mutagenesis and assay
of the recombinant mutant enzymes with a synthetic
model substrate. In fact, an earlier study has described
extensive mutagenesis within the dengue virus NS3 pro-
tease for ultraconserved residues among flaviviral pro-
teases and these residues were putatively involved in
catalysis or substrate binding [26]. However, activity of
the mutant proteases was assayed by SDS-PAGE analysis
of autoproteolytic cleavage of the NS2B-NS3 precursor
in vivo. Although this approach yielded semiquantitative
data for activity of the mutant enzymes, it did not pro-
vide precise numerical values for the kinetic activity of
the mutant proteases with substrates supplied for trans
cleavage reactions. Moreover, a number of residues such
as L115, S163 and I165 have not been included in that
investigation as their possible role for enzyme activity
was suggested later by data from structural experiments
[14,23]. Therefore, the changes in catalytic efficiency
which we have observed in the context of amino acid
exchanges could contribute to a refined model of sub-
strate specificity and active site conformation for the
dengue virus NS3 protease.
Methods
Construction of active site mutants of the dengue virus
NS2B(H)-NS3pro protease
Plasmid DNA encoding the NS2B(H)-NS3pro precursor
of dengue virus serotype 2 strain 16681 cloned in the
pTrcHisA expression vector (Invitrogen) containing resi-
dues 48-95 followed by residues 121-130 and the N-
terminal 180 amino acids of the NS3 protein was used
as template for site-directed mutagenesis by using the
QuickChange site-directed mutagenesis kit (Stratagene)
as described earlier [15]. All synthetic oligonucleotides
were purchased from Proligo Pty., Singapore. Mutagenic
primers were designed to induce alanine substitutions at
positions L115, D129, G133, T134, Y150, G151, N152,
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were carried out by using an automated thermal cycler
(Perkin Elmer). Additional restriction sites were incor-
porated in the primer sequence for screening purposes.
A catalytically inactive S135A mutant of NS3pro was
used as negative control. Plasmid DNA obtained from
recombinant clones was subjected to DNA sequence
analysis by using an ABI PRISM™Dye Terminator Cycle
Sequencing kit on a model 377 DNA sequencer (Perkin-
Elmer, Norwalk, USA). No mutations were found to be
present in the plasmid samples at non-targeted sites.
Expression and purification of the mutant NS2B(H)-
NS3pro proteases
Plasmid DNA containing recombinant sequences of the
dengue virus NS3pro mutants was transformed in E. coli
C41(DE3) host cells and cultures were incubated at 37°C
i nt h ep r e s e n c eo f0 . 1m MI P T Gf o r8h o u r s .P r o t e i n
complexes were purified from inclusion bodies by a
two-step procedure using a Hitrap chelating column
(Pharmacia) and a Superdex 75 HR 10/300 gel filtration
column (Pharmacia) as described earlier [20]. Purifica-
tion was performed under denaturing conditions in the
presence of 8 M urea and purified proteins were
refolded by step-wise dialysis using Spectra/Por 6 regen-
erated cellulose dialysis membranes (Spectrum Labora-
tories). Samples were concentrated by using Amicon
Ultra-15 centrifugal filter devices (Millipore). Protein
concentrations were determined by using a BioRad pro-
tein assay dye reagent kit based on the Bradford method
with bovine serum album (Sigma Chemistry) as stan-
dard. Protein samples were analyzed on 15% SDS-PAGE
gels using a Mini-Protein III electrophoresis system
(BioRad). Preparations of the refolded enzymes were
stored at -20°C in 0.1 M Tris-HCl, pH 9.0, 50% (v/v)
glycerol for up to 1 week.
Assay of enzymatic activity
Enzymatic activity of the NS2B(H)-NS3pro recombinant
proteases was assayed with the fluorogenic peptide sub-
strate, tBoc-Gly-Arg-Arg-4-methylcoumaryl-7-amide
(Peptides International), in 50 mM Tris-HCl, pH 9.0,
20% (v/v) glycerol, by using an automated microtiter
plate fluorescence reader (Perkin Elmer) at excitation
wavelength l = 355 nm and emission wavelength l =
460 nm as described previously [20]. Briefly, reactions
were initiated by mixing the substrate solution with the
enzyme and fluorescence signals were recorded at 5 min-
utes intervals over a period of 20 min at 37°C. Initial
velocities were corrected for inner filter effects as
described in the literature [27]. Concentrations of pro-
teases used in the assay were dependent on activity and
were varied between 0.15 μMa n d3 . 0μM, substrate
concentrations were in the range between 12.5 μMa n d
1.0 mM. Fluorescence signals were converted to product
formation by comparison with standard amounts of amc
(Sigma Chemistry). Kinetic parameters, Km and Vmax,
were obtained from measurement of corrected velocities
and Michaelis-Menten kinetics, v = Vmax [S]/[S]+Km,
were transformed into double-reciprocal Lineweaver-
Burk plots by non-linear regression analysis using the
GraphPad Prism 4 software. Three independent experi-
ments were carried out for each set of data points and
data are reported as mean ± SEM by one-way analysis
of variance calculated by using GraphPad InStat 3 soft-
ware. Standard deviations of the reported numerical
values were < 10%.
Results and discussion
Construction, expression and purification of active site
mutants in the dengue virus NS3 protease
The NS3 proteases of human-pathogenic flaviviruses
such as dengue virus and West Nile virus have received
substantial scientific attention as potential targets for
the development of antiviral therapeutics. The exquisite
selectivity of these proteases for their corresponding
polyprotein substrates can be explained by the existence
of specific binding pockets for amino acid side chains of
the substrate [28]. The aim of our study was a better
understanding of structural determinants of substrate
specificity of the dengue virus NS3 protease. To this
purpose, we have generated alanine substitutions at
selected positions within the active site, overexpressed,
biochemically purified and assayed enzymatic activity of
the recombinant proteins with the synthetic model sub-
strate GRR-amc as described earlier in the literature
[15]. The selection of residues potentially involved in
enzyme-substrate interactions was based on previous
reports for the closely related West Nile virus NS3 pro-
tease and predictions extracted from 3-dimensional
structures of the dengue virus NS3pro [14,24,25]. Resi-
dues L115, D129, Y150 and S163 were predicted to line
the S1 subsite of the protease, while N152 was proposed
to present a key residue in the S2 subsite. With the
exception of position 115, all these residues are strictly
conserved among all flaviviruses. An alignment of active
site residues for a number of flaviviral proteases is
shown in Fig. 1. A structural analysis of the WNV NS3
protease recently published by Robin et al. has sug-
gested a role for residue G133 in the formation of the
oxyanion hole [25]. A map of the dengue virus NS3 pro-
tease active site with residues putatively involved in
enzyme-substrate interaction is shown in Fig. 2[14]. Ala-
nine mutations were introduced in the NS3 protease at
residues L115, D129, G133, T134, Y150, G151, N152,
S 1 6 3a n dI 1 6 5b yu s i n gt h ep r e v i o u s l yd e s c r i b e dc o n -
struct NS2B(H)-NS3pro as a template for site-directed
mutagenesis by PCR [16].
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insoluble inclusion bodies and a two-step purification
under denaturing conditions by immobilized metal affi-
nity chromatography and size-exclusion chromatography
resulted in greater than 95% pure proteins as judged by
SDS-PAGE (Fig. 3). Refolding of the samples by step-
wise dialysis yielded enzymatically active proteins as
described earlier [20].
Analysis of autoproteolysis as described earlier for
mutants in the NS2B(H) activation sequence [15]
revealed that the Y150A and G151A mutants were com-
pletely inactive with no products of self-cleavage detect-
able (data not shown).
Kinetic analysis of active-site mutations
We have assayed the enzymatic activity of the mutant
enzymes by using the synthetic substrate tripeptide GRR
with a conjugated fluorescence reporter group, amc,
with inner filter effect correction as described earlier
[27]. Recombinant NS2B(H)-NS3pro proteases were
assayed for activity at various concentrations of protein
and substrate as described in Materials and Methods
and kinetic parameters, Km and kcat, were calculated
from Michaelis-Menten kinetics. The alanine mutations
introduced at selected residues within the active site of
the NS3 protease had marked effects on substrate bind-
ing (Km) and rates of substrate hydrolysis (kcat)w h e n
compared to the activity of the wild-type enzyme (Fig.
4). As shown by comparison of Km values, all mutations
except the L115A mutant resulted in effects on sub-
strate affinity and increased Km values, whereas catalytic
rates kcat appeared to be significantly reduced for all
mutants except L115A. The most notable effect was
observed for the Y150A and G151A mutants that
Figure 1 Multiple alignment of amino acid sequences in the active site region of flaviviral NS3 proteases. Numbers on the left indicate
the startpoint of the amino acid sequence in the viral polyprotein. The degree of conservation among the 10 sequences is represented by
background shading of the residues with red, blue, and green shading for 100%, 80-90%, and 60-70% residue conservation, respectively.
Residues within the dengue virus serotype 2 sequence substituted by alanine are labeled with asterisks. Abbreviations: DEN 1, 2, 3, 4, Dengue
Virus serotypes 1, 2, 3, 4 respectively; WNV, West Nile Virus; JEV, Japanese Encephalitis Virus; KUNV, Kunjin Virus; MVE, Murray Valley Encephalitis
Virus; YFV, Yellow Fever Virus; TBEV, Tick-Borne Encephalitis Virus.
Figure 2 Structure of the dengue virus NS3 protease active site. Panel A: Overall structure of the dengue virus NS3 serine protease in
complex with a partially resolved structure of the NS2B cofactor domain (in blue). Residues of the catalytic triad H51, D75 and S135 are shown
as blue-colored stick models. Data were obtained from the protein data bank at accession code 2FOM (14). Panel B: Zoom-in view of the NS3
protease active site. Residues located within the S1 and S2 binding pockets that were targeted by alanine substitution mutagenesis are shown
as element-coloured stick model, labeled in black. Residues labeled in blue represent the members of the catalytic triad H51, D75 and S135.
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assay and a 23-fold increase in enzyme concentration
over the amount used for the wild-type protein did not
result in detectable activity, thereby suggesting that
these mutations completely inactivate the enzyme. The
changes in catalytic efficiency observed for the mutant
NS3 enzymes can therefore be summarized in the order:
L115A>wild-type>T134A>S163A>G133A>D129A>
N152A>I165A.
G151 and G133
Contrary to our expectations, alanine substitution of
G151 yielded an enzyme with completely abolished
activity. G151 is invariantly present in the NS3
sequences of known flaviviruses and we speculated
that this residue might play a dual role in the stabiliza-
tion of the tetrahedral transition state intermediate
formed at S135 during substrate cleavage and to main-
tain structural stability of the E2-F2 strands in the pro-
tease fold [14]. G133 is part of the ultraconserved
GxSGxP motif found in flaviviral NS3 sequences and
most likely determines the optimal size and generates
the catalytically competent conformation of the oxya-
nion hole for the accommodation of the respective
substrate [25]. Earlier reports have proposed that sub-
strate-free conformations of the NS2B-NS3pro enzyme
contain a flipped peptide bond between T132 and
G133 which abrogates the active conformation of the
oxyanion hole and that formation of the active oxya-
nion hole by an induced fit mechanism requires the
presence of authentic substrates containing a P1′ resi-
due [14,23]. However, it was demonstrated recently
that the active conformation of the oxyanion hole in
WNV NS3 protease is maintained also in the presence
of inhibitors without a P1′ residue [25].
Alanine substitution of the G133 residue resulted in a
NS3 protease with only approximately 10-fold reduced
catalytic efficiency when compared with the wild-type
enzyme, thus suggesting some degree of conformational
freedom at this position.
Figure 3 SDS-PAGE analysis of purified proteases NS2B(H)-
NS3pro. Proteins were obtained by a two-step purification
procedure using immobilized metal affinity chromatography and
size-exclusion chromatography on a Superdex 75 HR10/300 GL
column as described under Methods. Proteins shown were loaded
in the presence of 8 M urea under denaturing conditions prior to
refolding. Lane M, molecular weight marker proteins with molecular
weight indicated; lane 1, NS2B(H)-NS3pro protease wild-type; lane 2,
inactive S135A mutant of NS3pro; lanes 3-11, purified protein
samples of nine active site mutants L115A, D129A, G133A, T134A,
Y150A, G151A, N152A, S163A and I165A in NS2B(H)-NS3pro,
respectively. The arrow indicates the band of NS2B(H)-NS3pro
migrating at an apparent molecular weight of 37 kDa. Samples
were run on 15% SDS-PAGE gels and stained with Coomassie
Brillant Blue.
Figure 4 Presentation of kinetic parameters for samples of
NS2B(H)-NS3pro wild-type and mutant derivatives. Samples
were assayed by using fluorescence emission from cleavage of the
peptide substrate GRR-amc at 37°C as described under Methods.
The bar graph shows a comparison of numerical constants obtained
for Km (panel A), kcat (panel B) and catalytic efficiency kcat/Km (panel
C) for the wild-type protein NS2B(H)-NS3pro and active site mutant
proteins L115A, D129A, G133A, T134A, N152A, S163A and I165A.
Samples of Y150A and G151A were inactive in the enzyme assay
and a 23-fold increase in enzyme concentration did not result in
detectable activity. Data represent the mean of triplicate
measurements and error bars are indicated.
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Substitution of Y150 by alanine yielded a NS3 protease
with completely abrogated activity, a finding in agree-
ment with earlier mutagenesis data for this residue from
WNV and dengue virus [24,25]. It was suggested that
Y150 could primarily stabilize the positively charged
side chain of the P1 arginine by an aromatic π -c a t i o n
interaction. An additional role for Y150 could be the
structural stabilization of the E2 strand in the C-term-
inal b-barrel of the NS3 protein.
S163
This position is structurally homologous to residue 226
of chymotrypsin which is part of the portal to the sub-
strate binding pocket and is conserved in all flavivirus
proteases. It was proposed earlier that G153 and S163
form a bulkier entry to the substrate binding pocket
[26]. Mutation of S163 to alanine in the WNV NS3 pro-
tease generated an inactive enzyme [24], whereas we
have found a 12-fold reduction in catalytic efficiency for
the dengue virus S163A mutant. This residue could play
ar o l ei ns u b s t r a t eb i n d i n gb yf o r m a t i o no fah y d r o g e n
bond with the substrate P1 arginine.
D129
Substitution of the invariant residue D129 by alanine
induced a large (39-fold) decrease in catalytic efficiency.
Chappell et al. have reported a 17-fold increase in Km
for the D129A mutant of the WNV protease, whereas
we have seen a 2.3-fold increase in Km and a 16-fold
decrease in kcat [24]. The precise role of this residue
requires further experimental analysis, however, the pos-
sibility exists that D129 participates both in substrate
binding by providing salt bridge or hydrogen bond inter-
actions with the substrate P1 arginine as well as in the
catalytic mechanism of the NS3 protease.
T134
Alanine substitutions of this residue had only minor
effects on enzymatic activity as demonstrated by a 2.2-
fold decrease in catalytic efficiency. T134 could provide
a weak interaction with the P1 arginine, presumably via
a hydrogen bond from its hydroxyl group.
L115
A V115F mutant of the WNV NS3 protease was enzy-
matically inactive most likely due to size restrictions
which prevented the substrate from occupying the S1
pocket [24], however, in the dengue virus NS3 protease
L115 appears to be located at a position relatively
remote from the S1 pocket (Fig. 2) [14]. For the L115A
mutant of dengue virus NS3 protease, we have observed
even a marginal increase in catalytic efficiency suggest-
ing that a smaller side chain could provide additional
flexibility for the accommodation of the P1 substrate.
N152
In contrast to findings with the WNV virus NS3 pro-
tease, the N152A mutation did not completely inactivate
the dengue virus enzyme but resulted in a substantial
60-fold reduction of catalytic efficiency. N152 is part of
the S2 subsite and presumably provides an interaction
w i t ht h es i d ec h a i no ft h eP 2s u b s t r a t ev i ah y d r o g e n
bonding [14].
I165
The role of this residue was not investigated in previous
studies although it is conserved throughout the flavivirus
NS3 proteases and was predicted to line the S1 pocket.
Mutation of this residue to alanine removes the bulky
side chain and results in a drastic increase in Km thus
suggesting a function in substrate binding rather than
catalysis, conceivably by a reduction of the size of the
S1 pocket.
Taken together, these results have largely confirmed
previous predictions for active site residues of the den-
g u ev i r u sN S 3p r o t e a s ea n dt h e r e f o r es u g g e s tt h a tt h e
residues selected in this study have probably a major
function for substrate binding and catalysis. In addition
to existing structural data we have further obtained
enzymatic evidence to suggest that the residues G133
and G151 play a role in the catalytic mechanism of the
dengue virus NS3 protease, presumably as structural ele-
ments of the oxyanion binding hole. Although our find-
ings for the dengue virus NS3 protease are essentially in
agreement with previous data for the WNV NS3 pro-
tease, we have observed that a number of residues such
as S163, N152 and I165 display distinct effects on
enzyme activity when substituted by alanine. These dif-
ferences could relate to subtle structural alterations in
the structures of the WNV and dengue virus proteases
[29]. Moreover, differences in substrate specificity were
recently explained by alteration of the substrate binding
pockets in the S2-S4 region by dissimilarities in NS2B
complexation between the dengue virus and WNV NS3
proteases [30]. It is also noteworthy that the S1 and S2
pockets of a proteolytic enzyme may not be the sole
determinants of specificity [31]. Nevertheless we believe
that the S1 and S2 residues identified in this study may
represent ideal targets for the design of antiviral inhibi-
tors against NS3 serine proteases of dengue virus and
possibly other flaviviruses.
Conclusions
The design of inhibitors against the flaviviral NS3 serine
proteases requires a precise knowledge of the structural
determinants of substrate binding and catalysis. In this
s t u d yw eh a v er e - v i s i t e dt h econformational properties
o ft h ed e n g u ev i r u sN S 3p r o t e a s ea c t i v es i t eb yas t r u c -
ture-guided mutagenesis approach of nine residues
located within the S1 and S2 binding pockets. Of these,
all with exception of L115 had prominent effects on
enzyme catalysis and therefore represent important
functional determinants for substrate specificity. To the
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time a kinetic analysis of mutations in the dengue virus
NS3 protease by a trans cleavage assay with a synthetic
peptide model substrate.
These structural requirements can be utilized in
informed drug discovery programs aiming at the discov-
ery of selective inhibitors against the flaviviral NS3
proteases.
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